Objective: This study was performed to document the clinical and radiographic results of consecutive patients with Crowe IV developmental dysplasia of the hip (DDH) treated by cementless total hip arthroplasty (THA) using an S-ROM femoral component with shortening derotational subtrochanteric osteotomy. Methods: Twenty-three hips of 21 patients with Crowe IV DDH were treated by cementless THA combined with shortening derotational subtrochanteric osteotomy from January 2005 to January 2011. The mean preoperative modified Harris hip score (mHHS) and University of California, Los Angeles (UCLA) activity score were 40.7 and 4.2, respectively. Results: The mean follow-up was 105 months. The mean mHHS and UCLA score improved to 87.0 and 9.1, respectively, at the latest follow-up. Nine of the 23 hips had a negative Trendelenburg sign. One of the 23 hips was outside the Lewinnek acetabular cup inclination safe range, and 3 of the 23 hips were outside the Lewinnek acetabular cup anteversion safe range. The probability of prosthesis survival was 100% at 5 years and 91.3% at 10 years. Conclusion: Patients with Crowe IV DDH can be treated by cementless THA combined with shortening derotational subtrochanteric osteotomy. This method can greatly improve hip joint function and relieve pain without significant complications.
Introduction
Persistence of hip dysplasia into adolescence and adulthood can lead to an abnormal gait, restricted abduction, reduced strength, and an increased rate of degenerative joint disease.
1 Crowe type IV developmental dysplasia of the hip (DDH) is characterized by a myriad of abnormalities of the hip joint caused by long-term dislocation of the femoral head, resulting in many obstacles to restoration of normal hip anatomy, 2 such as a high hip center; a small, narrow femoral canal; and increased femoral anteversion with a posteriorly positioned greater trochanter. [1] [2] [3] [4] Total hip arthroplasty (THA) has been widely accepted as the standard treatment for severe hip disease. [2] [3] [4] [5] [6] [7] [8] In this study, we enrolled patients with Crowe IV DDH treated by THA in which a cementless S-ROM femoral prosthesis (DePuy Orthopaedics, Warsaw, IN, USA) and shortening derotational subtrochanteric osteotomy were used. Their clinical and radiographic data were collected and analyzed. This study was performed because the findings will assist physicians in clinical practice.
Patients and methods
We retrospectively reviewed the clinical and radiographic data of consecutive patients with Crowe IV DDH treated by cementless THA combined with shortening subtrochanteric osteotomy from January 2005 to January 2011 in our institution.
The inclusion criteria were severe pain, considerable difficulty in walking, functional impairment while performing daily activities, low quality of life, and Crowe IV DDH. 2 The exclusion criteria were asymptomatic high hip subluxation, a history of hip surgery (e.g., osteotomy, trauma, etc.), inflammatory or oncologic diseases in the area of the operated hip joint, neuromuscular compromise in the symptomatic extremity, and incomplete follow-up. 2 All patients were evaluated preoperatively using the modified Harris hip score (mHHS); University of California, Los Angeles (UCLA) activity score; 36-Item Short Form Health Survey (SF-36); and limb-length discrepancy (LLD). Leg length measurements were performed at the clinical examination and involved calculation of the difference in the distance from the anterior superior iliac spine to the medial malleolus between the right and left leg. 2 A cementless S-ROM component (DePuy Orthopaedics) and cementless metalon-polyethylene bearing (DePuy Orthopaedics) were used in all patients.
Surgical technique
Preoperative X-ray templating was used to establish a thorough plan of acetabular reconstruction and choose the best route for the operation. Intravenous antibiotics and prophylaxis for thrombosis were also administered to all patients.
All patients were placed in the lateral position, and the posterior approach was applied. After detaching the external rotators, the deformed femoral head was removed using an L-shaped osteotomy appropriate for the S-ROM sleeve. 3 The elongated hypertrophic joint capsule was resected. 9 The psoas tendon was partially released. 9 Our goal was to position the acetabular component in the true acetabular rotation center. After identifying the true acetabular floor, the acetabulum was prepared. The acetabular soft tissue was used to locate the original joint plane. The transverse ligament was then used to confirm an accurate position for the hip center. 5, 9 The acetabulum was widened and deepened at a designated angle of abduction and anteversion. 5, 9 We used a small cup dimension to obtain osseous coverage of !70% of the weight-bearing superior portion of the cup. 5, 9 No patients needed acetabular bone grafting for augmentation of the roof. All acetabular components were placed medial to the wall in the original acetabulum.
The femur was prepared with the entry point on the osteotomy of the neck developed from within the calcar toward the greater trochanter as far laterally as necessary to allow the femoral component to be passed directly down the canal. 5,9 A shortening derotational subtrochanteric transverse osteotomy was required in all cases to facilitate easier hip reduction and avoid excessive limb lengthening with possible sciatic nerve stretching. About 1.0 to 1.5 cm below the lesser trochanter, the transverse osteotomy was performed using an oscillating saw perpendicular to the longitudinal axis of the femoral shaft. 5, 9 The amount of shortening was dependent upon the preoperative radiographic measurements and the intraoperative examination with traction. 5, 9 The femoral anteversion was corrected by derotation. During the operation, the sciatic nerve was not explored but palpated for the purpose of evaluation.
All patients underwent implantation of the S-ROM three-piece femoral component (DePuy Orthopaedics) made of titanium alloy without cement (Figures 1-3 ). Femoral heads of 22 and 28 mm were used in 17 and 4 hips, respectively. A porouscoated acetabular cup (Duraloc; DePuy Orthopaedics) was used in all hips with one or two dome screws for fixation. The cups ranged from 40 to 48 mm in outer diameter. No reinforcement rings, reconstruction cages, or structural femoral head autografts were used. No custom-made implants were required.
Postoperatively, oral celecoxib (200 mg once daily) was prophylactically administered as for inflammation. Physiotherapy was begun on the second day after surgery. Three days later, we usually encouraged the patients to walk with the help of walker. Two weeks later, they were able to walk on their own.
Postoperatively, the following patientreported outcome data were collected for all patients: mHHS, UCLA score, SF-36 score, LLD measurement, satisfaction level (1 ¼ unsatisfied, 2 ¼ somewhat satisfied, 3 ¼ satisfied, 4 ¼ very satisfied, and 5 ¼ extremely satisfied), and a binary satisfaction response (yes or no). Abduction strength was assessed with the Trendelenburg sign. All patients were then asked to return for a follow-up at 6 weeks, 3 months, 6 months, and 1 year after surgery and annually thereafter. Radiologic data were gathered at each clinical follow-up. The osteotomy site was evaluated by anteroposterior and lateral films of the pelvis, and bone union was defined based on the cortical continuity. We performed a radiographic analysis for evidence of loosening according to the methods proposed by Gruen et al. 10 and DeLee and Charnley.
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The inclination of the acetabular cup was calculated on the anteroposterior pelvic film, and the anteversion of the cup was also measured on the film using the method proposed by Pradhan. 12 Based on the inclination and anteversion, the cup was recognized as either within the safe range (40 AE 10 for inclination and 15 AE 10 for anteversion) or not as described by Lewinnek et al. 13 
Ethics
This study was approved by the Second Xiangya Hospital Committee for Clinical Research (No. 2012-S231), and informed consent was obtained from the patients and the parents or guardians of the patients participating in the study. The patients and their parents or guardians provided written informed consent for the publication of their individual clinical details and accompanying images.
Statistical analysis
All evaluable patients were included in the analysis. Analyses were performed using descriptive statistical methods. Variables following a normal distribution were evaluated using Student's t-test. For categorical variables, the chi-squared test or Fisher's exact test was applied as necessary. The significance level was set at a p value of <0.05.
Results
This study included 23 hips of 21 patients (Table 1 ). The patients comprised 19 Aseptic loosening of the acetabular component occurred in two patients (8.70%) and required revision. The revisions were performed 97 and 132 months after the index operation, respectively. The original femoral stems were not removed in the revision. Radiographic evidence of aseptic stem loosening was seen in three hips in three patients (13.04%). Of these patients, one had radiolucency in Gruen zone 2, and two had radiolucency in Gruen zone 6. In one patient, the hip was revised 105 months after the index operation. In the other two patients, the hip was revised 121 and 127 months after the index operation. The 5-year prosthesis survival rate was 100%, and the 10-year prosthesis survival rate was 91.30% ( Figure 4) . Table 1 . One (4.35%) of the 23 hips was outside the Lewinnek acetabular cup inclination safe range, and 3 (13.04%) of the 23 hips were outside the Lewinnek acetabular cup anteversion safe range. Overall cup malpositioning, whether in anteversion or inclination, was observed in 4 (17.39%) of the 23 hips. All femoral shortening osteotomies achieved union.
Details of the acetabular cup inclinations and anteversions are listed in
Three intraoperative nondisplaced fractures occurred at the level of the calcar during femoral stem insertion but were left untreated. One patient had sciatic nerve palsy, which fully recovered in about 6 months. Neither infection nor dislocation was observed after the operation. 
Discussion
We have herein reported our experience of using an S-ROM cementless stem combined with shortening osteotomy for the treatment of high hip dislocation. This operative method provided an acceptable outcome during a follow-up period of 61 to 136 months. The mHHS improvement, UCLA activity score improvement, patient satisfaction level, and 5-and 10-year prosthesis survival rates in the present study compare favorably with those in other series of Crowe IV DDH. [2] [3] [4] [5] [6] [7] [8] [9] According to the safe range proposed by Lewinnek et al., 13 the acetabular cup malposition rate in the present study was 17.39%. 13 All patients with malpositioning of the acetabular cup developed flexion pelvic tilt, which may increase the risk of inserting the cup with less or more anteversion than desired. According to our experience, the use of preoperative threedimensional computed tomography of the hip and intraoperative radiography were beneficial for correct insertion of the acetabular cup. Although malpositioning of the acetabular cup increases the risk of dislocation, no postoperative dislocation was observed in this study. There is a lack of statistical evidence that may prove that a malpositioned hip prosthesis increases the rate of polyethylene wear, the incidence of osteolysis, or the risk of prosthesis loosening.
Highly placed acetabular cups have a tendency to be associated with early prosthesis loosening because of their poor support from limited bone stock. 4, 8, 14, 15 Therefore, most authors recommend that placement of the acetabular component corresponds to that of the original acetabulum. 4, 8, 14, 15 However, because of the hypoplasia of the true acetabulum, it is usually difficult to achieve sufficient coverage for an acetabular component. In such situations, we use small, deeply seated components to obtain enough cup coverage. No acetabular component loosening was observed during a mean follow-up of 105 months in this series of patients. Notably, however, placing the acetabular component at the anatomical acetabular level while keeping the femoral prosthesis in the anatomical position would extensively lengthen the leg. 4, 8, 14, 15 It is widely accepted that lengthening of the leg by >4 cm could impair the sciatic or femoral nerve. 4, 16 Some authors have even proposed that for patients who have had LLD since childhood, over-lengthening by >2 cm may result in nerve palsy. 4, 17 In our study, we used transverse subtrochanteric shortening osteotomy to avoid these adverse effects. Compared with other types of subtrochanteric osteotomy such as step-cut, oblique, or chevron-shaped osteotomies, [18] [19] [20] [21] [22] transverse subtrochanteric osteotomy is much easier to perform and adjust rotational corrections.
Incongruence between the proximal and distal femoral canal diameters after subtrochanteric shortening osteotomy is a major problem in achieving secure fixation of the femoral stem in dysplastic hip arthroplasty. 3, 4 Secure fixation of the subtrochanteric osteotomy site is desired to provide a proper environment for bone healing, maintain the corrected anteversion until bony union, and ensure osseointegration of the Figure 4 . Survival proportions of patients femoral component. 3, 4 In the present study, we used the modular S-ROM cementless stem and achieved a good result. The modular S-ROM stem can provide rotational stability and compression pressure at the osteotomy site with a stepped proximal sleeve and polished distal flutes and fins individually in both the proximal and distal parts of the femur. 3, 4 The rotation alignment of the modular S-ROM stem neck can be freely adjusted around 360 , regardless of the type of rotational deformity of the proximal femur. 3, 4 Furthermore, during implant trialing, trial sleeves on modular implants can protect the fit of the stem in the proximal bone fragment. 3, 4 The length of the stem, which plays a critical role in the stability of the joint, must bypass the osteotomy by at least twice the diameter of the diaphysis. 3, 4 Few neurological complications have been reported in THA combined with shortening femoral osteotomy, 7 and one patient in the present study developed sciatic nerve palsy. Fortunately, the patient had complete return of function nearly 6 months after surgery. Patients with Crowe IV DDH usually have a narrow femoral canal. Use of the modular S-ROM stem in THA combined with femoral osteotomy may risk femoral fissuring or fracture. Three intraoperative nondisplaced fractures occurred at the level of the calcar during femoral stem insertion. We did not apply special treatment to these fractures, and fracture union was eventually achieved.
In conclusion, patients with Crowe type IV DDH can be treated by cementless THA combined with subtrochanteric shortening osteotomy. This method can greatly improve hip joint function and relieve pain without significant complications. However, the required techniques of the procedure and the potential preoperative and postoperative problems should not be underestimated. 
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